Neuropeptide Y (NPY) is produced in the brain and stimulates appetite , particularly for carbohydrate-rich foods
Longer-acting versions are often used in extended optimization protocols due to their sustained activity
Its activity intersects two major metabolic pathways simultaneously: the NAD+ biosynthesis pathway (by consuming nicotinamide, an NAD+ precursor, NNMT competes with the NAD+ salvage pathway) and the methyl-donor pathway (by consuming SAM, NNMT reduces the availability of methyl groups for epigenetic and metabolic methylation reactions)
A legitimate platform still reviews candidacy, safety, and follow-up needs
Quick Answer: Tirzepatide reduces systolic blood pressure by 5 to 10 mmHg and diastolic blood pressure by 2 to 5 mmHg in clinical trials, though it is not FDA-approved for hypertension treatment
The addition of GIP activation is what makes tirzepatide's results consistently superior in head-to-head comparisons